Drug recall · October 24, 2018
Clonazepam Orally Disintegrating Tablets USP recall
Why: Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clonazepam Orally Disintegrating Tablets USP, 2 mg., 60-count carton. RX only. Teva Pharmaceuticals USA, INC. North Whales, PA 19454. NDC 0555-0098-96
- Lots / codes
Lot # 34033752A, EXP 1/2020
- Quantity
- 1,373 60-count cartons
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Product was distributed throughout the United States to various distributors who may have further distributed the product.
- Initiated
- September 20, 2018 · Voluntary: Firm initiated
- Classified
- October 18, 2018
- Reported
- October 24, 2018
- Ended
- November 7, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clonazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.